Pfizer considers consumer business sale
Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription. The pharmaceutical giant is weighing options for its consumer health care business. It may spin off or sell the unit, which also produces Advil, Preparation H and the Centrum brand
Millions die suffering amid global opioid gap, report says
Report finds millions die suffering in part because of a global disparity that leaves many poor countries without opioid painkillers
P&G, in early vote, fends off activist investor Nelson Peltz Initial voting results show that Procter & Gamble successfully fended off an attempt activist investor Nelson Peltz to capture a seat on its board. Peltz, however, is not conceding, calling the vote too close on Tuesday.
Wal-Mart and United climb while Procter & Gamble slumps
Wal-Mart Stores and United Continental Holdings advance while Procter & Gamble declines
Pfizer may sell consumer unit
Pfizer considers selling Advil, other consumer brands as part of strategic review
Interest groups donated to Trump's record-breaking inauguration fund
A record-breaking $107 million poured in for President Trump’s inauguration celebration from corporate giants, business titans and a roster of NFL owners, raising new questions about the influence of money in politics. On Tuesday, the 58th Presidential Inaugural Committee (PIC), an organization
FBI director confirms investigation into Russia's alleged interference in 2016 election
FBI Director James Comey confirmed that the agency he oversees is investigating Russia's alleged meddling in the US presidential election.
Sean Spicer reads news articles to defend Trump's wiretapping claims
The president's press secretary began a filibuster by reading news reports for nearly 8 minutes, adding that President Trump stands by his tweets accusing President Obama of wiretapping him.
How Trump's Tweets Seem To Be Impacting Stocks and CEOs
Donald Trump is known for airing his grievances and musings on Twitter, but now his opinions seem to be directly impacting the U.S. stock market and investors. The most recent example came this morning after the president-elect said that he wants to reduce drug prices in his interview with Time